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Abstract
Introduction. Esophageal fibrovascular polyps are rare, be-
nign, intraluminal, submucosal tumor-like lesions, characterized
by pedunculated masses which can demonstrate enormous
growth. The most frequent symptoms are dysphagia, vomiting
and weight loss. Fibrovascular polyps with long stalks can re-
gurgitate into the airways and cause asphyxia. Esophageal in-
flammatory pseudotumor is extremely rare lesion accompanied
with various systemic manifestations as fever, anemia and
thrombocytosis. Case report. We presented a 29-year-old man
complaining of a long-lasting fever and dysphagia. He was
found to have huge pedunculated submucosal tumor of
esophagus, surgically completely resected. Histopathological
examination showed that this giant tumor, 24 u 9 u 6 cm, was a
fibrovascular polyp. The postoperative course was uneventful.
The preoperative fever, anemia and thrombocytosis disap-
peared and did not recur in the postoperative course. Conclu-
sion. We reported a patient with giant esophageal peduncu-
lated tumor with clinical manifestations of inflammatory pseu-
dotumor and histopathological picture of fibrovascular polyp,
that we have not found described in the literature before.
Key words:
polyps; esophagus; granuloma, plasma cell; diagnosis;
endosonography; histological techniques; surgical
procedures, operative; treatment outcome.
Apstrakt
Uvod. Fibrovaskularni polipi jednjaka su retke, benigne, intra-
luminalne, submukozne neoplazme na peteljci, koje mogu pos-
tiýi džinovski rast. Najÿešýi simptomi fibrovaskularnih polipa
jednjaka su otežano gutanje, povraýanje i mršavljenje. Fibrova-
skularni polipi sa dugom peteljkom se mogu povratiti u disajne
puteve izazivajuýi asfiksiju. Inflamatorni pseudotumor jednjaka
je veoma redak tumor, ÿesto udružen sa razliÿitim sistemskim
manifestacijama kao što su febrilnost, anemija i trombocitoza.
Prikaz bolesnika. Prikazali smo bolesnika starog 29 godina, sa
dugotrajnom febrilnošýu i disfagijom. Tokom ispitivanja kod
bolesnika je naĀen veliki submukozni tumor jednjaka na petelj-
ci, koji je hirurški odstranjen u celosti. Histopatološki pregled
ovog velikog tumora, 24 u 9 u 6 cm, pokazao je da se radilo o
fibrovaskularnom polipu. Postoperativni tok je protekao bez
komplikacija, a preoperativna febrilnost, anemija i trombocito-
za su nestale. Zakljuÿak. Ovo je prikaz sluÿaja bolesnika sa ve-
likim polipoidnim tumorom jednjaka koji se kliniÿki ponašao
kao zapaljenski pseudotumor, a mikroskopska slika je odgova-
rala fibrovaskularnom polipu, što nismo našli opisano u litera-
turi do sada.
Kljuÿne reÿi:
polipi; jednjak; granulom, plazmocelularni; dijagnoza;
endosonografija; histološke tehnike; hirurgija,
operativne procedure; leÿenje, ishod.
Introduction
Fibrovascular polyps (FPs) are rare, benign, intralumi-
nal, submucosal, tumor-like lesions characterized by the de-
velopment of pedunculated, intraluminal masses, which in
the esophagus can demonstrate an enormous growth. Dys-
phagia, vomiting, weight loss, and respiratory symptoms are
the most frequent complaints of patients with FP, and these
with long stalks can regurgitate into the pharynx or mouth
and cause asphyxia 1.
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Inflammatory pseudotumors (IPTs) are benign and rare
lesions, forming a group of etiologically, histologically, and
biologically heterogeneous lesions that are histologically
characterized by prominent inflammatory infiltrates 2. IPT
has been described in various organs but esophageal local-
ization is extremely rare. These quasineoplastic lesions may
mimic a malignant tumor clinically and radiologically 3.
Clinical presentation of patients with IPTs tends to be with
varying degrees of fever, iron-refractory anemia, and throm-
bocytosis 4.
We presented a 29-year-old male with fever of un-
known origin, malaise, anemia and thrombocytosis, who was
diagnosed and operated for a really giant esophageal poly-
poid tumor. The clinical manifestations of this unique lesion
with behavior of IP and histopathological picture of FP were
described with a review of the literature.
Case report
A 29-years-old Caucasian male, without any previous
medical history, was referred to the Military Medical Acad-
emy (MMA) Belgrade, Serbia, for further investigation due
to throat pain, dysphagia, and fever up to 39°C, malaise,
anemia and thrombocytosis, present for few months. The pa-
tient had nonselective anorexia and lost 7 kg of his body
mass for the last 4 months.
In the moment of the patient referral to MMA, his status
during physical examination was normal. There was no or-
gan enlargement, ascites or edema. Body temperature
showed high fever, up to 39°C.
Laboratory investigations showed some increased values:
the erythrocyte sedimentation rate (ESR) was 98 mm/h (nor-
mal: < 15 mm/h), C-reactive protein (CRP) 16.72 mg/L (nor-
mal range 0–3 mg/L), fibrinogen 8.9 g/L (normal range 2–4
g/L) platelets 833 u 109/L (normal range 140–450 u 109/L) and
gamma-glutamyl transferase (GGT) 78 U/L (normal range 0–
38 U/L). There was a decreases in the levels of red blood cell
(RBC) 3.6 u 1012/L (normal range 3.9–5.7 u 1012/L, hemoglo-
bin (Hgb) 83 g/L (normal range 120–180 g/L) and hematocrite
(Hct) 0.27 L/L (normal range 0.36–0.503 L/L). A blood film
showed a microcytic, hypochromic picture with hyperseg-
mented neutrophils. Urine sample was normal and repeated
blood, urine and stool cultures were negative. There was no se-
rological evidence of infection due to cytomegalovirus
(CMV), Ebstein-Barr virus (EBV), adenovirus, brucellosis,
psittacosis, mycoplasma, legionella, toxoplasma or Q fever.
Thyroid hormones were within normal range. Bone marrow
smear showed reactive hyperplasia. The purified protein de-
rivative (PPD) skin test was negative. Rheumatoid factors and
antinuclear antibodies (ANA) were negative. Serum immuno-
globulins were within normal limits.
Electrocardiogram (ECG) and echocardiogram showed
a normal heart function without evidence of vegetations.
Chest x-ray was normal as abdominal echosonogram.
Initial upper endoscopy demonstrated a large peduncu-
lated mass starting from cervical part of esophagus, on 21st
cm from the front teeth there was a stalk with 3 cm in di-
ameter, originating from the right esophageal wall. The tu-
mor stretched across the entire esophagus, up to gastric car-
dia. Tumor was covered with overlying mucosa and had mu-
cosal erosion on the top, without actual bleeding. The stom-
ach and duodenum were without any pathological changes
on mucosa. Initial biopsies were inconclusive.
Endoultrasonography (EUS) confirmed endoscopic
findings. Pedunculated submucosal tumor was starting from
lamina muscularis propria of cervical esophagus, the upper
diameter was 3 cm and the distal 6–9 cm. The tumor was
echoheterogenic, dominantly hypoechogenic.
Double-contrast barium meal examination demon-
strated normal deglutition act and giant pedunculated intra-
luminal mass, which completely filled the esophagus, up to
the gastric cardia, causing significant dilatation and obstruc-
tion (Figure 1). Tumor starts in the cervical part of esopha-
gus and contrast normally passes in the stomach (Figure 2A
and B).
Fig. 1 – Barium meal examination shows esophageal
enlargement with a huge tumor inside.
A computed tomographic (CT) scan of the chest
showed an intraluminal esophageal mass of 21 u 9 u 6 cm,
arising from the cervical part of the esophagus and reaching
the cardiac orifice of the stomach. Tumor mass fulfilled and
dilate the complete esophagus but without wall infiltration.
There was no evidence of metastasis or lymphadenopathy in
the thorax and abdomen (Figure 3).
After investigation was completed, operative treatement
was suggested to the patient and he accepted it.
In general anestesia we reached the esophagus through
the left lateral neck incision. A left esophageal wall was in-
cised in the length of 4 cm. Through this incision a huge pe-
dunculated tumor with smooth wall was visible. The stalk of
this tumor was 3 cm in its basis, originating from the right
esophageal wall. The stalk was cut and the basis checked by
frozen section, and no malignancy was found. The basis of
the stalk was sutured by absorbable sutures. An attempt to
remove the tumor through esophageal incision failed due to
its huge calibar and the esophagotomy was sutured in a two-
layered fashion. Median laparotomy was done and explora-
tion did not show any pathological findings in abdomen. After
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Fig. 3 – Thorax computed tomography – tumor fulfills the
esophagus without wall infiltration.
gastrotomy we found no pathological content in the stomach.
The tumor apex was prominent through the gastric cardia
and the tumor was completely removed, “delivered”, through
gastric incision (Figure 4). Gastrotomy was closed by a layer
of running absorbable sutures, abdominal cavity drained with
rubber drain and laparotomy closed.
Gross pathology demonstrated that the removed po-
lipoid tumor was penile – like in shape, 21 u 9 u 6 cm (Fig-
ure 5). The surface of the tumor was mainly smooth except
on the top where mucosal erosion was present (Figure 6). It
was open longitudinally; tissue on the cutting surface was
homogeneous, white color, smooth and shiny with foci of
mixoid degeneration and with tough and elastic consistency
(Figure 7). The proximal part of polyp ended with the stalk,
2 cm long.
Fig. 4 – The tumor is “delivering” from the stomach.
Fig. 5 – A complete tumor with a stalk.
Fig. 2 – Barium meal examination: A) The tumor basis starts in the cervical
esophagus; B) The top of the tumor is in front of the gastric cardia.
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Fig. 7 – Cutting surface of the tumor.
Histologic sections were fixed in formalin, routinelly
processed, embedded in paraffin and stained with hematoxy-
lin-eosin (H E). The immunohistochemistry analysis was
routinely processed on formalin fixed paraffin embedded
(FFPE) tissue sections thickness of 4 . After deparaffiniza-
tion and blocking of endogenous peroxidase activity by 3%
hydrogen peroxide, the sections were incubated with primary
antibodies with a Dako EnVision system. The following an-
tibodies were used: smooth muscle actin (SMA), CD34,
CD68, Ki-67 and S-100 protein. After incubation with sec-
ondary antibodies, the sections were visualized with 3-3’-
diaminobenzidine and were counterstained with Mayer’s
hematoxylin.
Microscopicaly, the polyp was mainly covered with
mature squamous epithelium, exept on the top (Figure 8A
and B), where mucosal erosion was present and covered by
necrotic detritus with underlying granulation tissue with dif-
fuse infiltration of mixture of lymphocytes, plasma cells and
neutrophyls. In the base of granulation tissue few scattered
atypical fibroblasts were found, mitotically inactive and
seeming regenerative. The tumor was composed from the
loose, focally mixoid and edematous collagen connective tis-
sue with foci of hyalinization. Inside the tumor lobules of
mature adipose tissue without lipoblasts were found (Figure
8C). The polyp was very well vascularized (Figure 8D and
E) with multiplied blood vessels of small and medium cali-
bar, venous and arterial type. Foci of inflammatory infil-
trates, mainly lymphocytes and plasma cells, were present
not only around ulceration but also throughout entire polyp,
especially perivasculary. Cappilary and bigger blood ves-
sels showed a positive reaction of endothelial cells on
CD34 (Figure 8F) and SMA, S-100 protein was negative.
Inside the tumor there were histiocytes with immunoreac-
tivity on CD68. In rare spindle cells Ki-67 showed positive
reaction.
The postoperative cours was uneventful. A double-
contrast barium meal examination on 7th postoperative day
showed no extravasation and normal passage through the
esophagus and stomach and the patient started oral feeding.
Postoperatively, the patient’s body temperature was normal,
anemia was corrected well as thrombocytosis (value of RBC
was 4.1 u 1012/L, Hgb 105 g/L, Hct 0.322% L/L, platelets 440
u 109/L).
Follow-up within 5 years showed that the patient was
without any complaints, without dysphagia and fever, with
laboratory findings in the normal range. Control upper en-
doscopy showed normal status on esophagus and stomach
and there was no tumor recurrence.
Discussion
Fibrovascular polyps of the esophagus are rare benign
tumors, comprising about 1% of all benign esophageal tu-
mors. However, they are the most common submucosal tu-
mor-like lesions of the esophagus, characterized by the de-
velopment of pedunculated, intraluminal masses that, in the
esophagus can demonstrate enormous growth. Giant FPs are
defined as polyps larger than 5 cm in maximal diameter.
They are slow growing, pedunculated tumor masses that of-
ten arise from the upper esophagus, at the pharyngo-
esophageal junction, Laimer’s triangle 5.
Inflammatory pseudotumors are benign and rare le-
sions, forming a group of etiologically, histologically, and
biologically heterogeneous tumefactive lesions that are
histologically characterized by prominent inflammatory
infiltrates 4. IPT has been described in various organs,
most commonly involving the lungs and orbit, but also
found in nearly every site in the body 6. These lesions
may mimic a malignant tumor clinically and radiologi-
cally 7. Recently there have been reports about multicen-
tric localization of IPT 8. Tumor size of IPT varies and
can be very huge. Esophageal localization is very rare as
their size over 20 cm9.
Fig. 6 – The tumor from the other side with mucosal ulceration.
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The majority of FPs occur in elderly people, aged 60–
70 years, but they have been reported also in a 5 months
old infant 10. Although IPT can occur at any age, in both
genders, it is most commonly present in children and young
adults 11.
The pathogenetic origin of FP is from the loose and
redundant submucosal tissue near the Laimer’s triangle.
Due to the lack of muscular support, this relatively mo-
bile tissue through years of esophageal peristalsis, trac-
tion and swallowing, is dragged along, elongated and
enlarged intraluminally 12. The etiology and pathogenesis
of IPT remain unclear, reactive-infectious, immunologi-
cal and idiopathic factors might play a role in their ini-
tiation and growth 13. Speculated etiology includes viral
infection, focal parenchymal necrosis with hemorrhage
secondary to trauma, coagulopathy or surgical trauma 14.
An immune-autoimmune mechanism has also been impli-
cated 15.
Fibrovascular polyps are covered with normal mucosa
and containing different amounts of fibrous, vascular, and
adipose tissue. Based on their histological composition, these
polypoid lesions have been termed as lipomas, fibromas, fi-
brolipomas, or fibroepithelial polyps in the literature. More
recently, the World Health Organization has classified them
as FPs, in their international histological classification sys-
tem 16. Malignant transformation is rare but has been re-
ported in esophageal polyps. The lipomatous components
can undergo sarcomatous changes, the squamous mucosa can
develop into squamous carcinomas and small polyps can de-
velop into adenocarcinoma 17.
Inflamatory pseadotumors can present as a single mass
or multiple masses with polymorphous inflammatory cell in-
filtrates and variable amounts of fibrosis, necrosis, granu-
lomatous reaction, and myofibroblastic spindle cells. The
term IPT denotes a histologically similar group of tumors,




Fig. 8 – A) Mucosal erosion on the top of the polyp with the underlying granulation tissue infiltrated with
lymphocytes, plasma cells, neutrophyl and eosinophyl granulocytes (HE, u20); B) Regulary stratified
squamous epithelium covering surface of the polyp out of ulceration (HE, u4); C) Fat tissue lobulus in the
connective tissue (HE, u10); D) Multiplied blood vessels, small and medium calibar (HE, u10); E) Vascular
spaces collored by actin (immunohistochemical reaction, LSAB+, u10); F) Endothelial cells with positive
reaction on CD34 (immunohistochemical reaction, LSAB+, u10).
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flammatory appearance that has been reported under a vari-
ety of additional descriptive terms, such as atypical fibro-
myxoid nodule, inflammatory fibroid polyp, inflammatory
pseudotumor, plasma cell granuloma, and pseudosarcoma-
tous myofibroblastic proliferation. The gross features of eso-
phageal IPT vary from polypoid to diffuse non-polypoid, and
are likely to occur in the distal esophagus or the esophago-
cardial junction 18.
Since polyp is slowly growing, it may remain asymp-
tomatic for years until it reaches a large size. Dysphagia,
vomiting, chronic gastrointestinal bleeding, weight loss and
respiratory symptoms are the most frequent complaints of
patients with FPs. Though biologically benign, these giant
FPs can have dramatic and even life-threatening presenta-
tions because these polyps with long stalks, however, can re-
gurgitate into the pharynx or mouth and cause death from as-
phyxiation if the larynx is occluded 19.
A distinguishing feature of IPT, in up to 50% of cases,
is the presence of a varying degree of inflammatory syn-
drome consisting of persistent fever, weight loss, malaise,
iron-refractory anemia, moderate leukocytosis, thrombocyto-
sis, polyclonal hyper-globulinemia and elevated erythrocyte
sedimentation rate. Many of these features can be related to
the production of inflammatory mediators such as cytokines
and particularly Interleukin-1, which has a wide range of lo-
cal and systemic effects, as tumor-specific inflammatory re-
sponse 10. Our patient demonstrated several aspects of this
syndrome, i.e. fever, malaise, weight loss, and thrombocyto-
sis. Both clinical and laboratory manifestations tend to re-
solve rapidly after surgery 4, as was the case in the presented
patient.
Usually, the diagnosis is made by imaging and endo-
scopic studies. Barium double-contrast examination of the
esophagus usually shows a sausage-shaped mass with multi-
ple filling defects, which originates in the cervical esophagus
and extends to the lower esophagus 20.
Endoscopy usually shows an intraluminal mass that is
mobile and covered with normal mucosa. The presence of
easily bleeding ulcer on the top can be observed by endos-
copy, leading to the suspicion of malignancy. Careful exami-
nation of the upper esophageal sphincter may reveal the stalk
of pedunculated mass. EUS has been reported as a method to
demonstrate the submucosal origin of polyps 21. EUS also
provides information on a diameter of a polyp, as well as its
vascularity at insertion point 22. The submucosal location can
make endoscopic or tru-cutt biopsies difficult to obtain good
specimens and this histopathological specimens are often in-
conclusive or misdiagnosed. The definitive diagnosis is often
made based on histopathological analysis of surgically re-
moved specimens of FP or IPT 23.
CT scanning and magnetic resonance imaging (MRI)
can be useful to diagnose FP. In particular, MRI of the neck
and thorax might be decisive in the choice of treatment by
demonstrating the origin of the pedicle and the composition
of a polyp. If the mass consists predominantly of fat with a
minimal blood supply, the risk of bleeding during an endo-
scopic treatment is small. In case the polyp is rich with vas-
cular structures, endoscopic resection can be troublesome
due to uncontrollable bleeding. Preoperative identifying the
place and site of a polyp’s stalk, planning of cervical incision
opposite to the origin is possible 24.
Histological differentiation of FP from IPT is somewhat
difficult 25. This difficulty is partly due to the lack of exact
histological definition of each lesion that gives rise to the no-
sological confusion 26. Key histological findings in estab-
lishing the diagnosis of IPT are the co-existence of variable
numbers of inflammatory cells and spindle cells, consisting
of fibroblasts and myofibroblasts and with varying degrees
of fibrosis. This variation in the extent of inflammatory in-
filtrate and fibrosis suggests that this is a dynamic and
evolving inflammatory process 27.
The first choice of therapy for this giant, pedunculated,
intraluminal masses is surgical excision 28. Surgical man-
agement is necessary because malignancy can not be ex-
cluded preoperatively and this is the only way to got defini-
tive diagnosis and to allow oral feeding. In addition, surgical
therapy is recommended because of the progressive nature of
the lesion and the underlying risk of asphyxiation and sudden
death 29.
Management can be complex and varies from endo-
scopic removal to total esophagectomy, usually is a combi-
nation of different types of endoscopical and surgical tech-
niques. Endoscopic removal should be reserved for small,
pedunculated tumors without evidence of muscularis pro-
pria involvement on EUS. Endoscopic removal has rarely
been reported for giant esophageal inflammatory fibrous
polyps because the procedure is technically demanding and
hemostasis is difficult to ascertain, but it is possible 30. Sur-
gical excision is preferable by a left-sided cervical ap-
proach and, when tumor is too big, removal should be done
through gastrotomy by open access or in laparoscopic
way 9, 31, 32. In case of a large-size polyp, a thoracotomy
may be necessary 33. If there is no stalk, the operative enu-
cleation should be recommended 34. Complete surgical re-
section by esophagectomy, whether partial or total, should
be the procedure of choice for large and obstructing eso-
phageal IPTs or any tumor with muscularis propria in-
volvement, decreasing the risk of recurrence35. Nowadays,
a minimally invasive approach is more often used in eso-
phageal surgery for these challenging cases 36. In our case,
we succeed to remove complete tumor without esophagec-
tomy, using a bi-approach.
Local excision of FP is curative and recurrence after
resection is very rare. However, there are reports on recur-
rent FP that recurred within years. Some authors believe
that residual tissue around the pedicle’s base may cause
recurrent polyp formation, which hypothetically can be the
reason for recurrence. Local recurrence of giant IPS is rare
but may occur if there is incomplete resection of the le-
sion 37. Due to the risk of recurrence, patients should un-
dergo to endoscopical and radiological surveillance for
several years 38.
In the literature, there are several reports in which corti-
costeroids were successfully used for the treatment of IPT 39.
The use of chemotherapy and radiation for IPT treatment is
still controversial 40.
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Conclusion
The presented case illustrates the complexities involved
in diagnosing and the management of giant esophageal pe-
dunculated tumors. This unique lesion starts in the upper
esophagus and has histopathological picture of FP with clini-
cal manifestations and behavior of IPT, i.e. young ages, fe-
ver, malaise, weight loss, and thrombocytosis that resolved
after operation. To our knowledge, such a case has not been
described in the literature before.
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